BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 18433986)

  • 1. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to ACTH in opsoclonus-myoclonus.
    Pranzatelli MR; Kao PC; Tate ED; Chaves E; Chez M; Dobyns WB; Kang H; Rothner DA
    Neuropediatrics; 1993 Jun; 24(3):131-3. PubMed ID: 8395029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy.
    Nemni R; Braghi S; Natali-Sora MG; Lampasona V; Bonifacio E; Comi G; Canal N
    Ann Neurol; 1994 Oct; 36(4):665-7. PubMed ID: 7944301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
    Rakocevic G; Raju R; Dalakas MC
    Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular flutter, generalized myoclonus, and trunk ataxia associated with anti-GQ1b antibodies.
    Zaro-Weber O; Galldiks N; Dohmen C; Fink GR; Nowak DA
    Arch Neurol; 2008 May; 65(5):659-61. PubMed ID: 18474744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin.
    de Beer F; Schreurs MW; Foncke EM
    Clin Neurol Neurosurg; 2009 Sep; 111(7):643-4. PubMed ID: 19442432
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
    Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
    J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
    Baizabal-Carvallo JF
    J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of autoantigens in pediatric opsoclonus-myoclonus syndrome.
    Blaes F; Fühlhuber V; Preissner KT
    Expert Rev Clin Immunol; 2007 Nov; 3(6):975-82. PubMed ID: 20477144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic ophthalmological syndromes.
    Constantinescu A
    Oftalmologia; 1996; 40(3):214-8. PubMed ID: 8916442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of opsoclonus-myoclonus syndrome associated with anti-central nervous system antibody].
    Ushiyama M; Ishida K; Ikeda S; Imai H; Yanagisawa N
    Rinsho Shinkeigaku; 1994 Sep; 34(9):898-902. PubMed ID: 7820964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Posner JB
    J Pediatr; 1997 Jun; 130(6):855-7. PubMed ID: 9202603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.